secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
CIK:        0001137883
Form:       8-K
Filed at:   2021-10-29T23:59:59+00:00
Accession:  0001104659-21-131777
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Brainstorm Cell Therapeutics appoints Dr. Menghis Bairu to Board; Director Sankesh Abbhi to retire
--------------------------------------------------------------------------------

- Bairu appointed to Board effective Oct 28, 2021; receives $30K annual cash award in biannual installments.
- Bairu is founder/CEO of Proxenia Venture Partners and Chairman/CEO of Bairex.
- Abbhi will not stand for re-election at 2021 Annual Meeting; retirement not due to any dispute.
- Abbhi served on Board since March 30, 2020.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1137883/000110465921131777/0001104659-21-131777-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1137883/000110465921131777/tm2131336d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-131777

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer